ISpecimen Historical Income Statement
| ISPC Stock | USD 4.29 0.07 1.66% |
Historical analysis of ISpecimen income statement accounts such as Interest Income of 356.7 K or Depreciation And Amortization of 1.2 M can show how well iSpecimen performed in making a profits. Evaluating ISpecimen income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of ISpecimen's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining iSpecimen latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether iSpecimen is a good buy for the upcoming year.
ISpecimen |
About ISpecimen Income Statement Analysis
iSpecimen Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to ISpecimen shareholders. The income statement also shows ISpecimen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
ISpecimen Income Statement Chart
Add Fundamental
Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Total Revenue
Total revenue comprises all receipts iSpecimen generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of iSpecimen minus its cost of goods sold. It is profit before ISpecimen operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from ISpecimen's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into iSpecimen current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iSpecimen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade ISpecimen Stock refer to our How to Trade ISpecimen Stock guide.At present, ISpecimen's Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Total Other Income Expense Net is expected to grow to about 73.4 K, whereas Depreciation And Amortization is forecasted to decline to about 1.2 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 1.0M | 1.2M | 2.1M | 1.2M | Interest Income | 11.4K | 169.3K | 339.8K | 356.7K |
ISpecimen income statement Correlations
Click cells to compare fundamentals
ISpecimen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
ISpecimen income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Interest Income | (1.7M) | (2.1M) | (2.1M) | (69.6K) | 109.0K | 114.4K | |
| Interest Income | 630.0 | 437.0 | 11.4K | 169.3K | 339.8K | 356.7K | |
| Depreciation And Amortization | 804.5K | 819.7K | 1.0M | 1.2M | 2.1M | 1.2M | |
| Interest Expense | 1.7M | 2.1M | 2.1M | 239.0K | 230.8K | 219.2K | |
| Selling General Administrative | 2.9M | 3.3M | 7.0M | 8.9M | 7.7M | 5.9M | |
| Selling And Marketing Expenses | 1.4M | 1.8M | 2.4M | 3.4M | 4.0M | 2.6M | |
| Total Revenue | 4.3M | 8.2M | 11.1M | 10.4M | 9.9M | 8.9M | |
| Gross Profit | 2.2M | 4.6M | 5.9M | 5.6M | 5.1M | 4.7M | |
| Other Operating Expenses | 8.2M | 10.6M | 17.1M | 20.6M | 21.1M | 15.6M | |
| Operating Income | (3.9M) | (2.4M) | (5.9M) | (10.2M) | (11.2M) | (10.6M) | |
| Net Income From Continuing Ops | (4.7M) | (4.7M) | (9.0M) | (10.2M) | (11.1M) | (11.7M) | |
| Ebit | (3.9M) | (2.6M) | (6.9M) | (10.0M) | (11.2M) | (10.6M) | |
| Research Development | 993.3K | 1.4M | 1.8M | 2.7M | 3.6M | 2.1M | |
| Ebitda | (3.1M) | (1.7M) | (5.9M) | (8.8M) | (9.1M) | (8.6M) | |
| Cost Of Revenue | 2.1M | 3.6M | 5.2M | 4.8M | 4.8M | 4.2M | |
| Total Operating Expenses | 6.1M | 7.0M | 11.8M | 15.8M | 16.3M | 11.4M | |
| Reconciled Depreciation | 635.0K | 819.7K | 1.0M | 1.2M | 2.1M | 1.1M | |
| Income Before Tax | (4.9M) | (4.7M) | (9.0M) | (10.2M) | (11.1M) | (11.7M) | |
| Total Other Income Expense Net | (1.0M) | (2.2M) | (3.0M) | (59.8K) | 69.9K | 73.4K | |
| Net Income Applicable To Common Shares | (4.7M) | (4.7M) | (9.0M) | (10.2M) | (9.2M) | (9.7M) | |
| Net Income | (4.7M) | (6.8M) | (10.0M) | (9.0M) | (11.1M) | (11.7M) | |
| Income Tax Expense | (157K) | 2.1M | 1.1M | (1.2M) | 3.0 | 2.85 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iSpecimen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ISpecimen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ispecimen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ispecimen Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iSpecimen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade ISpecimen Stock refer to our How to Trade ISpecimen Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ISpecimen. If investors know ISpecimen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ISpecimen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (18.12) | Revenue Per Share 19.19 | Quarterly Revenue Growth (0.04) | Return On Assets (0.44) | Return On Equity (1.09) |
The market value of iSpecimen is measured differently than its book value, which is the value of ISpecimen that is recorded on the company's balance sheet. Investors also form their own opinion of ISpecimen's value that differs from its market value or its book value, called intrinsic value, which is ISpecimen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ISpecimen's market value can be influenced by many factors that don't directly affect ISpecimen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ISpecimen's value and its price as these two are different measures arrived at by different means. Investors typically determine if ISpecimen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ISpecimen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.